Troglitazone improves psoriasis and normalizes models of proliferative skin disease: ligands for peroxisome proliferator-activated receptor-gamma inhibit keratinocyte proliferation - Ellis,C.N.; Varani,J.; Fisher,G.J.; Zeigler,M.E.; Pershadsingh,H.A.; Benson,S.C. (Arch Dermatol, 2000)